Literature DB >> 2495341

Sphingolipid biosynthesis by rat liver cells: effects of serine, fatty acids and lipoproteins.

T O Messmer1, E Wang, V L Stevens, A H Merrill.   

Abstract

The effects of circulating factors that might influence de novo sphingolipid biosynthesis were examined with rat liver cells by following the incorporation of [14C]serine into sphingosine and sphinganine, the predominant long-chain base backbones of hepatic sphingolipids. The rate of long-chain base formation depended on the concentration of [14C]serine in the medium and exhibited saturation kinetics. Long-chain base formation was stimulated by another precursor, palmitic acid, but stearic, oleic, linoleic and linolenic acids were inhibitory. This kinetic behavior indicates that long-chain base formation in liver is affected by the availability of the substrates of the initial enzyme of this pathway, serine palmitoyltransferase. Since liver is also exposed to sphingolipids associated with circulating lipoproteins, the effects of various lipoprotein fractions were determined and each appeared to decrease long-chain base formation. These results suggest that hepatic long-chain base biosynthesis can be stimulated by increases in the circulating levels of the precursors serine and palmitic acid whereas some other fatty acids and lipoproteins decrease the flux through this pathway.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2495341     DOI: 10.1093/jn/119.4.534

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  8 in total

1.  Increased sphingomyelin content of plasma lipoproteins in apolipoprotein E knockout mice reflects combined production and catabolic defects and enhances reactivity with mammalian sphingomyelinase.

Authors:  Ts Jeong; S L Schissel; I Tabas; H J Pownall; A R Tall; X Jiang
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

2.  TRPV1 activation prevents nonalcoholic fatty liver through UCP2 upregulation in mice.

Authors:  Li Li; Jing Chen; Yinxing Ni; Xiaoli Feng; Zhigang Zhao; Peijian Wang; Jing Sun; Hao Yu; Zhencheng Yan; Daoyan Liu; Bernd Nilius; Zhiming Zhu
Journal:  Pflugers Arch       Date:  2012-03-07       Impact factor: 3.657

3.  Myristic acid increases dihydroceramide Δ4-desaturase 1 (DES1) activity in cultured rat hepatocytes.

Authors:  Hélène Ezanno; Jérôme le Bloc'h; Erwan Beauchamp; Dominique Lagadic-Gossmann; Philippe Legrand; Vincent Rioux
Journal:  Lipids       Date:  2011-12-03       Impact factor: 1.880

Review 4.  The twists and turns of sphingolipid pathway in glucose regulation.

Authors:  Gergana M Deevska; Mariana N Nikolova-Karakashian
Journal:  Biochimie       Date:  2010-05-31       Impact factor: 4.079

Review 5.  Killing tumours by ceramide-induced apoptosis: a critique of available drugs.

Authors:  Norman S Radin
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

6.  Integration of lipidomics and transcriptomics data towards a systems biology model of sphingolipid metabolism.

Authors:  Shakti Gupta; Mano R Maurya; Alfred H Merrill; Christopher K Glass; Shankar Subramaniam
Journal:  BMC Syst Biol       Date:  2011-02-08

7.  Nutraceutical agents with anti-inflammatory properties prevent dietary saturated-fat induced disturbances in blood-brain barrier function in wild-type mice.

Authors:  Ryusuke Takechi; Menuka M Pallebage-Gamarallage; Virginie Lam; Corey Giles; John C Mamo
Journal:  J Neuroinflammation       Date:  2013-06-19       Impact factor: 8.322

8.  Serum metabolomic signatures discriminate early liver inflammation and fibrosis stages in patients with chronic hepatitis B.

Authors:  Haijun Huang; Zeyu Sun; Hongying Pan; Meijuan Chen; Yongxi Tong; Jiajie Zhang; Deying Chen; Xiaoling Su; Lanjuan Li
Journal:  Sci Rep       Date:  2016-08-08       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.